Nosocomial infections in patients with cancer Journal Article
| Authors: | Kamboj, M.; Sepkowitz, K. A. |
| Article Title: | Nosocomial infections in patients with cancer |
| Abstract: | Nosocomial infections are those that become evident 48 h or more after a patient is admitted for treatment in a hospital or in another health-care setting. These infections cause substantial morbidity and mortality in patients who are immunosuppressed. Over the past few decades, understanding of host vulnerability has improved and more rigorous management and infection-control practices have been adopted for treating susceptible populations. Despite efforts, outbreaks continue to occur. In this Review, we outline current knowledge of the incidence and microbiology of various nosocomial infections in patients with cancer-a large, immunosuppressed population. © 2009 Elsevier Ltd. All rights reserved. |
| Keywords: | leukemia; clinical trial; disease course; mortality; review; hepatitis b; hepatitis c; nonhuman; temozolomide; drug megadose; antineoplastic agent; neoplasms; drug eruption; incidence; morbidity; prevalence; aciclovir; cyclophosphamide; immunoglobulin; steroid; hematopoietic stem cell transplantation; acute lymphoblastic leukemia; risk assessment; monoclonal antibody; hospitals; antibiotic resistance; disease severity; hematologic malignancy; malignant neoplastic disease; antivirus agent; purine derivative; clostridium difficile infection; virus infection; hospital infection; methicillin resistant staphylococcus aureus; vancomycin resistant enterococcus; vancomycin; immune deficiency; hepatitis b vaccine; influenza vaccine; quinoline derived antiinfective agent; catheter infection; clostridium difficile; infection control; influenza; virus strain; palivizumab; ribavirin; infection risk; alemtuzumab; antimycobacterial agent; chickenpox vaccine; hepatitis c vaccine; meticillin; oseltamivir; pentostatin; sialidase inhibitor; chickenpox; influenza virus a; influenza virus b; legionella; multidrug resistance; mycobacteriosis; parainfluenza virus; parainfluenza virus infection; respiratory syncytial pneumovirus; respiratory virus; tuberculosis; viral respiratory tract infection; viral upper respiratory tract infection; virus pneumonia; cross infection; influenza, human; respiratory syncytial virus infections |
| Journal Title: | Lancet Oncology |
| Volume: | 10 |
| Issue: | 6 |
| ISSN: | 1470-2045 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2009-06-01 |
| Start Page: | 589 |
| End Page: | 597 |
| Language: | English |
| DOI: | 10.1016/s1470-2045(09)70069-5 |
| PUBMED: | 19482247 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 3" - "Export Date: 30 November 2010" - "CODEN: LOANB" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work